Genetic News and Research

RSS

Leading experts to discuss latest pharmacogenomic research at European Lung Cancer Conference

Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010.

4 Mar 2010

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.

4 Mar 2010

Study: Bacteria, fungi and other microbes live in our gut are essential contributors to good health

The thousands of bacteria, fungi and other microbes that live in our gut are essential contributors to our good health. They break down toxins, manufacture some vitamins and essential amino acids, and form a barrier against invaders. A study published today in Nature shows that, at 3.3 million, microbial genes in our gut outnumber previous estimates for the whole of the human body.

4 Mar 2010

SEBM announces the 2010 winners of Young Investigator Award

SEBM is pleased to announce the 2010 winners of the Young Investigator Award. This is a $500 travel grant for undergraduate/ graduate students and/or individuals within 5 years of receiving doctoral degrees who are members of the Society to attend the Experimental Biology 2010 meeting in Anaheim in April 2010.

4 Mar 2010

CureDuchenne: Scientific advisors to come together to find cure for DMD

Today, CureDuchenne, a nonprofit dedicated to raising funds and awareness for Duchenne Muscular Dystrophy (DMD), announced that on March 19, 2010 the organization’s scientific advisors from around the country will come together in the fight to find a cure for Duchenne Muscular Dystrophy.

4 Mar 2010

MHAUS introduces new MH Mock Drill Training Kit to better prepare for MH emergencies

The Malignant Hyperthermia Association of the United States introduces a new MH Mock Drill Training Kit for Operating Room Staff to better prepare for MH emergencies

4 Mar 2010

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Biomoda, Inc. (www.biomoda.com) and Advanced Medical Imaging and Genetics (www.amigenics.com), an innovative medical clinic specializing in prevention and early detection of disease, announced their intent to collaborate on a variety of projects to advance technology for the early detection of lung and other cancer.

4 Mar 2010

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

A scientific "Renaissance man" whose work spans the fields of mathematics, linguistics, biotechnology and polymer physics, Erez Lieberman-Aiden, graduate student at the Harvard-MIT Division of Health Sciences and Technology, has been named the winner of the prestigious $30,000 Lemelson-MIT Student Prize. Lieberman-Aiden, one of four 2010 $30,000 Lemelson-MIT Collegiate Student Prize winners announced today, was selected for the breadth and depth of his innovations.

4 Mar 2010

Prolonged use of HRT may increase risk of lung cancer

Women aged 50 to 76 who take estrogen plus progestin may have an increased risk of lung cancer, according to a new study published in the pre-print online edition of the Journal of Clinical Oncology.

4 Mar 2010

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein

Concordia University is pleased to announce that Dr. Peter D. Pawelek, Assistant Professor, Department of Chemistry and Biochemistry was awarded a grant from the Thalassemia Foundation of Canada to study molecular mechanisms of a virulence factor protein from an opportunistic pathogen that affects thalassemia patients.

3 Mar 2010

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s DNA Vaccines 2010 in New Orleans, LA concerning the formulation and topical administration of the DermaVir therapeutic vaccine for HIV/AIDS. DNA Vaccine 2010 invites leading scientists to report on the latest research in the progressive field of DNA or Genetic Vaccines.

3 Mar 2010

Study: Offspring of two parents with schizophrenia more likely to develop same illness

Offspring of two parents with schizophrenia or bipolar disorder appear more likely to develop the same illness or another psychiatric condition than those with only one parent with psychiatric illness, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Mar 2010

MJFF for Parkinson's Research awards $500,000 grant to neuroscientist at Mayo Clinic

For his work contributing to a potential new treatment approach for Parkinson's disease, the Michael J. Fox Foundation for Parkinson's Research has awarded a $500,000 grant to a neuroscientist at the Mayo Clinic campus in Florida.

3 Mar 2010

Investigators use ANNs to recognize risk factors of AD in patients with MCI

Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer's disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment. In a groundbreaking study published in the February 2010 issue of the Journal of Alzheimer's Disease investigators successfully used artificial neural networks (ANNs) to help understand the causal relation between multiple factors and the occurrence of neurodegenerative disorders.

3 Mar 2010

Study: Patients with community-acquired pneumonia who develop AKI more likely to die after discharge

Patients hospitalized with even mild to moderate community-acquired pneumonia who develop acute kidney injury (AKI) are more likely to die after discharge than pneumonia patients whose kidneys remain healthy, according to a University of Pittsburgh School of Medicine study in the February issue of Kidney International.

3 Mar 2010

Combination of two targeted therapies effective against subset of gastric cancers: Study

A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a study at UCLA's Jonsson Comprehensive Cancer Center has found.

3 Mar 2010

InterSystems Ensemble platform enables first successful electronic transmission of genetic data

InterSystems Corporation, the global leader in software for connected healthcare, today announced that InterSystems Ensemble® was the software platform for the first-ever successful electronic transmission of comprehensive genetic data. The information was sent cross-country from Boston-based Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to Intermountain HealthCare in Salt Lake City, Utah. The announcement about reaching this milestone in personalized medicine came at the HIMSS10 conference.

2 Mar 2010

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional pharmacokinetic data presented at the meeting confirms that C1-INH concentrate has a longer half-life than other treatment options for HAE, which protects patients from rebound attacks.

2 Mar 2010

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

2 Mar 2010

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented today at the 2010 American Academy of Allergy, Asthma & Immunology Annual Meeting.

2 Mar 2010

Genetic News and Research

Leading experts to discuss latest pharmacogenomic research at European Lung Cancer Conference

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

Study: Bacteria, fungi and other microbes live in our gut are essential contributors to good health

SEBM announces the 2010 winners of Young Investigator Award

CureDuchenne: Scientific advisors to come together to find cure for DMD

MHAUS introduces new MH Mock Drill Training Kit to better prepare for MH emergencies

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

Prolonged use of HRT may increase risk of lung cancer

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Study: Offspring of two parents with schizophrenia more likely to develop same illness

MJFF for Parkinson's Research awards $500,000 grant to neuroscientist at Mayo Clinic

Investigators use ANNs to recognize risk factors of AD in patients with MCI

Study: Patients with community-acquired pneumonia who develop AKI more likely to die after discharge

Combination of two targeted therapies effective against subset of gastric cancers: Study

InterSystems Ensemble platform enables first successful electronic transmission of genetic data

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Sequencing & Genomics: Elevating Science and Healthcare eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News